Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

Literature DB >> 15894755

Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?

Abstract

A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15894755 PMCID： PMC1768957 DOI： 10.1136/hrt.2004.057190

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

32 in total

1. [Changes in xanthine oxidase activity in patients with circulatory failure].

Authors: Z A Bakhtiiarov
Journal: Ter Arkh Date: 1989 Impact factor: 0.467

2. Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium.

Authors: E D Jarasch; C Grund; G Bruder; H W Heid; T W Keenan; W W Franke
Journal: Cell Date: 1981-07 Impact factor: 41.582

3. Liver xanthine oxidase increase in mice in three patholgoical models. A possible defence mechanism.

Authors: E Tubaro; B Lotti; G Cavallo; C Croce; G Borelli
Journal: Biochem Pharmacol Date: 1980-07-01 Impact factor: 5.858

4. Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure.

Authors: Ronald S Freudenberger; Richard P Schwarz; Joanne Brown; Alan Moore; Douglas Mann; Michael M Givertz; Wilson S Colucci; Joshua M Hare
Journal: Expert Opin Investig Drugs Date: 2004-11 Impact factor: 6.206

5. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression.

Authors: G N Rao; M A Corson; B C Berk
Journal: J Biol Chem Date: 1991-05-05 Impact factor: 5.157

6. Reduction of reperfusion injury of human myocardium by allopurinol: a clinical study.

Authors: J A Gimpel; J R Lahpor; A J van der Molen; J Damen; J F Hitchcock
Journal: Free Radic Biol Med Date: 1995-08 Impact factor: 7.376

7. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

Authors: Giuseppe Mercuro; Cristiana Vitale; Elena Cerquetani; Sandra Zoncu; Martino Deidda; Massimo Fini; Giuseppe M C Rosano
Journal: Am J Cardiol Date: 2004-10-01 Impact factor: 2.778

8. Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

Authors: Niels Engberding; Stephan Spiekermann; Arnd Schaefer; André Heineke; Antje Wiencke; Maja Müller; Martin Fuchs; Denise Hilfiker-Kleiner; Burkhard Hornig; Helmut Drexler; Ulf Landmesser
Journal: Circulation Date: 2004-10-04 Impact factor: 29.690

9. Physical training improves endothelial function in patients with chronic heart failure.

Authors: B Hornig; V Maier; H Drexler
Journal: Circulation Date: 1996-01-15 Impact factor: 29.690

10. Allopurinol pretreatment improves postoperative recovery and reduces lipid peroxidation in patients undergoing coronary artery bypass grafting.

Authors: J G Coghlan; W D Flitter; S M Clutton; R Panda; R Daly; G Wright; C D Ilsley; T F Slater
Journal: J Thorac Cardiovasc Surg Date: 1994-01 Impact factor: 5.209

14 in total

Review 1. Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate.

Authors: R H H van den Heuvel; B Curti; M A Vanoni; A Mattevi
Journal: Cell Mol Life Sci Date: 2004-03 Impact factor: 9.261

Review 2. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

Authors: V Katsi; G Georgiopoulos; A Laina; E Koutli; J Parissis; C Tsioufis; P Nihoyannopoulos; D Tousoulis
Journal: Heart Fail Rev Date: 2017-11 Impact factor: 4.214

3. Effects of Greek legume plant extracts on xanthine oxidase, catalase and superoxide dismutase activities.

Authors: Chrysoula I Spanou; Aristidis S Veskoukis; Dimitrios Stagos; Kalliopi Liadaki; Nectarios Aligiannis; Apostolos Angelis; Alexios-Leandros Skaltsounis; Maria Anastasiadi; Serkos A Haroutounian; Dimitrios Kouretas
Journal: J Physiol Biochem Date: 2011-10-08 Impact factor: 4.158

Review 4. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Authors: Pál Pacher; Alex Nivorozhkin; Csaba Szabó
Journal: Pharmacol Rev Date: 2006-03 Impact factor: 25.468

Review 5. Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges.

Authors: Mitja Lainscak; Markus S Anker; Stephan von Haehling; Stefan D Anker
Journal: Herz Date: 2009-12 Impact factor: 1.443

Review 6. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?

Authors: Mark S Segal; Elizabeth Gollub; Richard J Johnson
Journal: Eur J Nutr Date: 2007-09-01 Impact factor: 5.614

7. Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study.

Authors: Nihayet Bayraktar; Suleyman Kilic; Mehmet Refik Bayraktar; Nurten Aksoy
Journal: J Clin Lab Anal Date: 2010 Impact factor: 2.352